Literature DB >> 9804283

Binding of amyloid beta-protein to intracellular brain proteins in rat and human.

I Ray1, A Chauhan, H M Wisniewski, J Wegiel, K S Kim, V P Chauhan.   

Abstract

Amyloid beta-protein (Abeta), in its soluble form, is known to bind several circulatory proteins such as apolipoprotein (apo) E, apo J and transthyretin. However, the binding of Abeta to intracellular proteins has not been studied. We have developed an overlay assay to study Abeta binding to intracellular brain proteins. The supernatants from both rat and human brains were found to contain several proteins that bind to Abeta 1-40 and Abeta 1-42. No major difference was observed in the Abeta binding-proteins from brain supernatants of patients with Alzheimer's disease and normal age-matched controls. Binding studies using shorter amyloid beta-peptides and competitive overlay assays showed that the binding site of Abeta to brain proteins resides between 12-28 amino acid sequence of Abeta. The presence of several intracellular Abeta-binding (AbetaB) proteins suggests that these proteins may either protect Abeta from its fibrillization or alternatively promote Abeta polymerization. Identification of these proteins and their binding affinities for Abeta are needed to assess their potential role in the pathogenesis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804283     DOI: 10.1023/a:1020744216699

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

Review 1.  Role of free radicals in aging and disease.

Authors:  D Harman
Journal:  Ann N Y Acad Sci       Date:  1992-12-26       Impact factor: 5.691

2.  The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma.

Authors:  A Koudinov; E Matsubara; B Frangione; J Ghiso
Journal:  Biochem Biophys Res Commun       Date:  1994-12-15       Impact factor: 3.575

3.  An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease.

Authors:  S D Yan; J Fu; C Soto; X Chen; H Zhu; F Al-Mohanna; K Collison; A Zhu; E Stern; T Saido; M Tohyama; S Ogawa; A Roher; D Stern
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

4.  Surface phosphorylation by ecto-protein kinase C in brain neurons: a target for Alzheimer's beta-amyloid peptides.

Authors:  M V Hogan; Z Pawlowska; H A Yang; E Kornecki; Y H Ehrlich
Journal:  J Neurochem       Date:  1995-11       Impact factor: 5.372

5.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Authors:  W J Strittmatter; K H Weisgraber; D Y Huang; L M Dong; G S Salvesen; M Pericak-Vance; D Schmechel; A M Saunders; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Authors:  D Burdick; B Soreghan; M Kwon; J Kosmoski; M Knauer; A Henschen; J Yates; C Cotman; C Glabe
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

7.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

8.  Amyloid beta-protein stimulates casein kinase I and casein kinase II activities.

Authors:  A Chauhan; V P Chauhan; N Murakami; H Brockerhoff; H M Wisniewski
Journal:  Brain Res       Date:  1993-11-26       Impact factor: 3.252

9.  Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro.

Authors:  P E Fraser; J T Nguyen; D R McLachlan; C R Abraham; D A Kirschner
Journal:  J Neurochem       Date:  1993-07       Impact factor: 5.372

10.  Hydrogen peroxide mediates amyloid beta protein toxicity.

Authors:  C Behl; J B Davis; R Lesley; D Schubert
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

View more
  3 in total

Review 1.  Neuroinflammatory processes in Alzheimer's disease.

Authors:  Michael T Heneka; M Kerry O'Banion; Dick Terwel; Markus Peter Kummer
Journal:  J Neural Transm (Vienna)       Date:  2010-07-15       Impact factor: 3.575

2.  Interaction of intracellular beta amyloid peptide with chaperone proteins.

Authors:  Virginia Fonte; Wadim Jan Kapulkin; Vadim Kapulkin; Andrew Taft; Amy Fluet; David Friedman; Christopher D Link
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

3.  The molecular assembly of amyloid aβ controls its neurotoxicity and binding to cellular proteins.

Authors:  Claudia Manzoni; Laura Colombo; Paolo Bigini; Valentina Diana; Alfredo Cagnotto; Massimo Messa; Monica Lupi; Valentina Bonetto; Mauro Pignataro; Cristina Airoldi; Erika Sironi; Alun Williams; Mario Salmona
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.